Neuron-specific enolase expression in multiple myeloma.
Sharma
Ricky A
RA
Department of Radiotherapy, Royal Marsden Hospital, London, UK. ras20@le.ac.uk
Wotherspoon
Andrew C
AC
Cook
Gary
G
Morgan
Gareth J
GJ
Huddart
Robert A
RA
D000230:Adenocarcinoma / Q000556:secondary / Q000628:therapy; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001536:Bence Jones Protein / Q000652:urine; D014408:Biomarkers, Tumor / Q000032:analysis; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary; D003937:Diagnosis, Differential; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000378:metabolism*; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010751:Phosphopyruvate Hydratase / Q000096:biosynthesis*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy
D014408:Biomarkers, Tumor; D007074:Immunoglobulin G; D001536:Bence Jones Protein; D010751:Phosphopyruvate Hydratase